top of page

Exploring Dog Dementia


Introduction:

Cognitive dysfunction syndrome (CDS), also known as canine cognitive dysfunction (CCD) or doggy dementia, is an age-related neurobehavioral disorder that affects a significant proportion of aging dogs. Just like humans, dogs can experience cognitive decline as they grow older. This article aims to delve into the topic of cognitive dysfunction in dogs, examining its causes and symptoms. Moreover, we will explore the potential benefits of exercise and the role of medium-chain triglycerides (MCTs) in managing and potentially mitigating cognitive dysfunction in our canine companions.



Understanding Cognitive Dysfunction in Dogs:

Cognitive dysfunction in dogs shares several similarities with Alzheimer's disease in humans. It is characterized by a progressive decline in cognitive functions such as memory, learning, perception, and awareness. Affected dogs may display changes in behavior, including disorientation, altered sleep patterns, decreased social interaction, increased anxiety, and house-soiling accidents.

The exact cause of cognitive dysfunction in dogs is not fully understood. However, it is believed to result from a combination of genetic, environmental, and age-related factors.


One study by Habiba et el. (2021) conducted on a population of senior dogs aimed to investigate the underlying mechanisms of age-related cognitive decline, which is similar to Alzheimer's disease in humans. The researchers observed the brains of these dogs and discovered the presence of two abnormal protein aggregates: amyloid-β oligomers and hyperphosphorylated tau.


Amyloid-β oligomers are small, soluble protein clusters that are known to impair neuronal function and contribute to the formation of plaques, a hallmark of Alzheimer's disease. Hyperphosphorylated tau refers to tau protein molecules with excessive phosphate groups, which can lead to the formation of neurofibrillary tangles, another characteristic feature of Alzheimer's.The accumulation of these abnormal protein deposits was closely associated with the dogs' cognitive dysfunction. The researchers conducted a battery of cognitive tests and observed a correlation between the severity of cognitive impairment and the density of amyloid-β oligomers and hyperphosphorylated tau in the brain tissue.



Exercise and Cognitive Function in Dogs:

Research suggests that regular physical exercise has numerous positive effects on cognitive function in dogs. Exercise not only promotes cardiovascular health and weight management but also enhances brain function and mental well-being. Engaging in physical activities stimulates blood flow to the brain, leading to improved oxygenation and nutrient delivery.

A study by Cotman et al. (2012) examined the effects of exercise on the brain function of aged dogs. The results demonstrated that regular aerobic exercise, such as brisk walks or swimming, enhanced cognitive performance and reduced the risk of cognitive decline. The researchers observed increased neurogenesis (the growth of new neurons) and improved spatial learning and memory in exercising dogs compared to sedentary ones.

Exercise also helps alleviate stress and anxiety in dogs, which are commonly associated with cognitive dysfunction. By promoting mental and physical stimulation, exercise can contribute to the overall well-being of aging dogs, slowing down the progression of cognitive decline.



Role of Medium Chain Triglycerides (MCTs):

Medium-chain triglycerides, a type of dietary fat, have gained attention in recent years for their potential cognitive benefits in both humans and dogs. MCTs are metabolized differently from long-chain fatty acids and can be readily converted into ketones, which serve as an alternative energy source for the brain.

A study by Pan et al. (2010) investigated the effects of dietary MCTs on cognitive function in aged dogs. The results showed that dogs fed a diet enriched with MCTs exhibited improved cognitive abilities, including better learning and memory performance, compared to dogs fed a control diet. MCT supplementation also correlated with reduced brain oxidative stress, suggesting a neuroprotective effect.

Furthermore, MCTs have shown promise in managing cognitive dysfunction in dogs by improving mitochondrial function and reducing neuroinflammation. These effects contribute to maintaining neuronal health and reducing the accumulation of harmful substances in the brain.


Conclusion:

Cognitive dysfunction in dogs can have a profound impact on their quality of life and the well-being of their owners. Fortunately, research suggests that regular exercise and the inclusion of medium-chain triglycerides in the diet can be valuable strategies for managing cognitive decline in dogs.

Exercise promotes brain health, stimulates neurogenesis, and reduces stress and anxiety, thereby slowing down the progression of cognitive dysfunction. On the other hand, dietary supplementation with medium-chain triglycerides enhances cognitive function, provides an alternative energy source for the brain, and offers neuroprotective effects.

It is important to consult with a veterinarian to develop a tailored approach for each individual dog affected by cognitive dysfunction. By incorporating exercise and appropriate dietary modifications, we can potentially improve the cognitive abilities and overall well-being of our beloved canine companions in their golden years.


References:


Habiba U, Ozawa M, Chambers JK, Uchida K, Descallar J, Nakayama H, Summers BA, Morley JW, Tayebi M. Neuronal Deposition of Amyloid-β Oligomers and Hyperphosphorylated Tau Is Closely Connected with Cognitive Dysfunction in Aged Dogs. J Alzheimers Dis Rep. 2021 Oct 6;5(1):749-760. doi: 10.3233/ADR-210035. PMID: 34870101; PMCID: PMC8609497.

Cotman CW, Head E. Exercise improves cognition in Alzheimer's disease and potentially in canine cognitive dysfunction. Alzheimer's Research & Therapy. 2012;4(3):20.

Pan Y, Larsen JT, Wagenmakers AJ, et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. British Journal of Nutrition. 2010;103(12):1746-1754.


Commentaires


bottom of page